FDA estimates the overall compliance costs of the rule to be from $174 million to $187 million in one-time costs and $149 million to $185 million in annual operating costs.
The FDA expects the compliance costs of the rule to increase operating costs on an annual basis.
The FDA expects the compliance costs of the rule to dramatically decrease operating costs on an annual basis.